Table 2.
Site of initial recurrences of mass-forming cholangiocarcinoma
| Site of recurrences | No. of patients (%) |
|---|---|
| Solitary recurrence | |
| Surgical margin | 4 (9.8%) |
| Liver remnant | 4 (9.8%) |
| Regional lymph node | 4 (9.8%) |
| Aortocaval lymph node | 4 (9.8%) |
| Peritoneum | 1 (2.4%) |
| Lung | 2 (4.9%) |
| Bone | 3 (7.3%) |
| Multiple recurrences | |
| Surgical margin and liver remnant | 2 (4.9%) |
| Surgical margin and regional lymph node | 3 (7.3%) |
| Surgical margin and aortocaval lymph node | 1(2.4%) |
| Surgical margin, liver remnant and regional lymph node | 3(7.3%) |
| Surgical margin, liver remnant and aortocaval lymph node | 1(2.4%) |
| Surgical margin, regional lymph node and peritoneum | 1(2.4%) |
| Surgical margin, liver remnant, regional lymph node and peritoneum | 1(2.4%) |
| Surgical margin, liver remnant, regional lymph node and bone | 1(2.4%) |
| Surgical margin, liver remnant, regional lymph node and aortocaval | 1(2.4%) |
| lymph node | |
| Liver remnant and aortocaval lymph node | 1(2.4%) |
| Regional lymph node and aortocaval lymph node | 1(2.4%) |
| Regional lymph node and bone | 1(2.4%) |
| Regional lymph node and peritoneum | 1(2.4%) |